SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 2 filers reported holding SYNDAX PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $355 | -26.2% | 24,410 | +6.4% | 0.00% | – |
| Q2 2023 | $481 | +99.6% | 22,939 | +101.9% | 0.00% | – |
| Q1 2023 | $241 | +1.3% | 11,364 | +21.4% | 0.00% | – |
| Q4 2022 | $238 | -99.9% | 9,364 | +11.1% | 0.00% | – |
| Q3 2022 | $203,000 | -97.9% | 8,429 | -98.4% | 0.00% | -100.0% |
| Q3 2021 | $9,863,000 | +36.6% | 516,098 | +22.8% | 0.00% | 0.0% |
| Q2 2021 | $7,219,000 | -26.5% | 420,420 | -4.2% | 0.00% | 0.0% |
| Q1 2021 | $9,816,000 | +157.4% | 439,017 | +156.1% | 0.00% | – |
| Q4 2020 | $3,813,000 | – | 171,439 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 8,076 | $174,522 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 46 | $994 | 0.00% |